Back to Search
Start Over
Denali Therapeutics Announces Publication of Two New Papers Describing Its Blood-Brain Barrier Delivery Technology in Science Translational Medicine
- Source :
- ICT Monitor Worldwide. May 28, 2020
- Publication Year :
- 2020
-
Abstract
- (GlobeNewswire) - Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases, today announced publication [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- ICT Monitor Worldwide
- Publication Type :
- News
- Accession number :
- edsgcl.625052972